Next-Gen CAR-T takes on leukemia that escaped earlier treatments
NCT ID NCT04016129
First seen Apr 25, 2026 · Last updated Apr 28, 2026 · Updated 1 time
Summary
This study tests a new type of CAR-T cell therapy for people with B-cell leukemia that does not have the CD19 marker or has come back after CD19-targeted treatment. The therapy uses a patient's own immune cells, modified to attack multiple targets on leukemia cells. The goal is to control the disease and improve outcomes for up to 100 participants aged 6 months and older.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for B-CELL LEUKEMIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Shenzhen Geno-immune Medical Institute
RECRUITINGShenzhen, Guangdong, 518000, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Zhongxi Children Hospital
RECRUITINGShijiazhuang, Hebei, 050006, China
Contact
-
Zhujiang Hospital of Southern Medical University
RECRUITINGGuangzhou, Guangdong, 510282, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.